• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在体外受精周期中增加促性腺激素剂量并不能纠正最初的低反应。

Increasing the gonadotrophin dose in the course of an in vitro fertilization cycle does not rectify an initial poor response.

作者信息

Khalaf Y, El-Toukhy Tarek, Taylor A, Braude P

机构信息

Assisted Conception Unit, 4th Floor Thomas Guy House, Guy's Hospital, St. Thomas' Street, SE1 9RT, London, UK.

出版信息

Eur J Obstet Gynecol Reprod Biol. 2002 Jul 10;103(2):146-9. doi: 10.1016/s0301-2115(02)00036-2.

DOI:10.1016/s0301-2115(02)00036-2
PMID:12069737
Abstract

OBJECTIVE

To evaluate the value of increasing the gonadotrophin dose after 5 days of controlled ovarian stimulation in IVF patients who show an initial poor response to stimulation.

SUBJECTS AND METHODS

We identified all IVF cycles between January 1992 and March 1996 in which ovarian response after 5 days of controlled ovarian hyperstimulation (COH) with 225-300 IU per day of human menopausal gonadotrophins (hMG; Metrodin or Pergonal) was monitored by measurement of serum estradiol concentrations (n=596 patients). According to estradiol concentration, the daily dose of hMG was doubled or increased to 450 IU in 193 patients (group A) or maintained the same in 403 patients (group B). Further cycle monitoring was achieved using serial ultrasound and serum estradiol measurements.

RESULTS

The two groups were age-matched. Group A patients experienced a higher cancellation rate despite having a higher mean number of hMG ampoules (59.5 versus 36.2) and a longer duration of stimulation (12.2 versus 10.8 days). They achieved lower levels of serum estradiol on days 9 and 10 of stimulation, produced a lower mean number of oocytes per retrieval (5.8 versus 8.9) and had a lower clinical pregnancy rate per cycle (8.3 versus 23.4%) compared to group B. All differences were statistically significant.

CONCLUSION

The poor outcome of cycles with initial low response to COH appears not to be averted by doubling or increasing the hMG dose after 5 days of stimulation.

摘要

目的

评估在体外受精(IVF)患者中,对初始刺激反应不佳者在控制性卵巢刺激5天后增加促性腺激素剂量的价值。

对象与方法

我们确定了1992年1月至1996年3月期间所有的IVF周期,这些周期中,每天使用225 - 300国际单位人绝经期促性腺激素(hMG;Metrodin或Pergonal)进行控制性卵巢过度刺激(COH)5天后,通过测量血清雌二醇浓度来监测卵巢反应(n = 596例患者)。根据雌二醇浓度,193例患者(A组)将hMG的每日剂量加倍或增加至450国际单位,403例患者(B组)维持原剂量不变。通过连续超声检查和血清雌二醇测量对周期进行进一步监测。

结果

两组年龄匹配。A组患者尽管平均使用的hMG安瓿数量更多(59.5支对36.2支)且刺激时间更长(12.2天对10.8天),但取消率更高。与B组相比,他们在刺激第9天和第10天的血清雌二醇水平较低,每次取卵的平均卵母细胞数量较少(5.8个对8.9个),每个周期的临床妊娠率较低(8.3%对23.4%)。所有差异均具有统计学意义。

结论

对于初始对COH反应低的周期,在刺激5天后加倍或增加hMG剂量似乎无法避免不良结局。

相似文献

1
Increasing the gonadotrophin dose in the course of an in vitro fertilization cycle does not rectify an initial poor response.在体外受精周期中增加促性腺激素剂量并不能纠正最初的低反应。
Eur J Obstet Gynecol Reprod Biol. 2002 Jul 10;103(2):146-9. doi: 10.1016/s0301-2115(02)00036-2.
2
The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.人绝经期促性腺激素与高纯度尿源性促卵泡生成素对降调节的正常促性腺激素水平女性体外受精结局的影响
Hum Reprod. 1996 Jun;11(6):1209-13. doi: 10.1093/oxfordjournals.humrep.a019357.
3
New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.地屈孕酮在 IVF 促性腺激素预备周期中的新应用:一项纳入 516 个首次 IVF/ICSI 周期的随机对照试验。
Hum Reprod. 2018 Feb 1;33(2):229-237. doi: 10.1093/humrep/dex367.
4
Clinical evaluation of three different gonadotrophin-releasing hormone analogues in an IVF programme: a prospective study.在体外受精方案中对三种不同促性腺激素释放激素类似物的临床评估:一项前瞻性研究。
Eur J Obstet Gynecol Reprod Biol. 2002 Jul 10;103(2):140-5. doi: 10.1016/s0301-2115(01)00297-4.
5
450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.450国际单位与600国际单位促性腺激素用于卵巢反应不良患者的控制性卵巢刺激:一项随机对照试验
Fertil Steril. 2015 Dec;104(6):1419-25. doi: 10.1016/j.fertnstert.2015.08.014. Epub 2015 Sep 8.
6
Relationship between the threshold of ovarian sensitivity to human menopausal gonadotrophin stimulation and in-vitro fertilization treatment outcome.卵巢对人绝经期促性腺激素刺激的敏感性阈值与体外受精治疗结局之间的关系。
Hum Reprod. 1995 Dec;10(12):3198-201. doi: 10.1093/oxfordjournals.humrep.a135887.
7
Comparison of highly purified FSH (metrodin-high purity) with pergonal for IVF superovulation.高纯度促卵泡激素(高纯度美诺孕)与 Pergonal 用于体外受精超排卵的比较。
J Assist Reprod Genet. 1998 Feb;15(2):65-9. doi: 10.1007/BF02766827.
8
The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.低剂量人绒毛膜促性腺激素联合人绝经期促性腺激素方案对接受体外受精卵巢刺激的低促性腺激素性性腺功能减退症妇女的影响。
Clin Endocrinol (Oxf). 2018 Jan;88(1):77-87. doi: 10.1111/cen.13481. Epub 2017 Oct 16.
9
Low-dose human menopausal gonadotrophin versus clomiphene citrate in subfertile couples treated with intrauterine insemination: a randomized controlled trial.低剂量人绝经期促性腺激素与枸橼酸氯米酚在宫腔内人工授精治疗不孕夫妇中的应用:一项随机对照试验。
Hum Reprod. 2015 May;30(5):1079-88. doi: 10.1093/humrep/dev062. Epub 2015 Mar 18.
10
Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.Corifollitropin alfa 序贯高纯度 HMG 与重组 FSH 在年轻卵巢低反应患者中的应用:一项多中心随机对照临床试验。
Hum Reprod. 2017 Nov 1;32(11):2225-2233. doi: 10.1093/humrep/dex296.

引用本文的文献

1
Live birth rates following individualized dosing algorithm of follitropin delta in a long GnRH agonist protocol.长 GnRH 激动剂方案中应用个体化重组促卵泡激素 δ 剂量算法后的活产率。
Reprod Biol Endocrinol. 2023 May 16;21(1):45. doi: 10.1186/s12958-023-01090-w.
2
A Narrative Review Discussing the Efficiency of Personalized Dosing Algorithm of Follitropin Delta for Ovarian Stimulation and the Reproductive and Clinical Outcomes.一篇叙述性综述:探讨促卵泡素δ个性化给药算法用于卵巢刺激的效率以及生殖和临床结局。
Diagnostics (Basel). 2023 Jan 4;13(2):177. doi: 10.3390/diagnostics13020177.
3
Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation.
口服药物,包括枸橼酸氯米芬或芳香化酶抑制剂与促性腺激素联合用于接受体外受精的女性的控制性卵巢刺激。
Cochrane Database Syst Rev. 2017 Nov 2;11(11):CD008528. doi: 10.1002/14651858.CD008528.pub3.
4
Comparative prospective study of 2 ovarian stimulation protocols in poor responders: effect on implantation rate and ongoing pregnancy.对卵巢反应不良者的两种卵巢刺激方案的比较前瞻性研究:对种植率和持续妊娠的影响
Reprod Health. 2015 May 30;12:52. doi: 10.1186/s12978-015-0039-2.
5
Demographic characteristics and clinical profile of poor responders in IVF / ICSI: A comparative study.体外受精/卵胞浆内单精子注射中低反应者的人口统计学特征和临床概况:一项比较研究。
J Hum Reprod Sci. 2010 May;3(2):91-4. doi: 10.4103/0974-1208.69343.
6
Is there a recommended maximum starting dose of FSH in IVF?体外受精中促卵泡激素(FSH)的推荐最大起始剂量是多少?
J Assist Reprod Genet. 2007 Aug;24(8):343-9. doi: 10.1007/s10815-007-9134-9. Epub 2007 Jun 17.
7
The practical implications of a raised serum FSH and age on the risk of IVF treatment cancellation due to a poor ovarian response.血清促卵泡激素升高及年龄对因卵巢反应不良导致体外受精治疗取消风险的实际影响。
J Assist Reprod Genet. 2004 Jul;21(7):257-62. doi: 10.1023/b:jarg.0000042011.67696.85.